【発明の名称】システインプロテアーゼのICE/ced-3系の置換アシルジペプチジル抑制剤

Japanese Patent JP2002527504

A

This invention is directed to novel (substituted)acyl dipeptidyl ICE/ced-3 family inhibitor compounds. The invention is also directed to pharmaceutical compositions containing these compounds, as well as the use of such compositions in the treatment of patients suffering inflammatory, autoimmune and neurodegenerative diseases, for the prevention of ischemic injury, and for the preservation of organs that are to undergo a transplantation procedure.

WO/2023/139514	MULTICOMPONENT COMPOSITION COMPRISING EPIGALLOCATECHIN GALLATE AND SAFFRON DRY EXTRACT, AND ITS USE IN THE PREVENTION AND TREATMENT OF PARKINSON'S DISEASE
WO/1997/004767	HYDROXYL RADICAL SCAVENGER
JP2014507372	Substituted carbamoylcycloalkyl acetic acid derivative as a NEP inhibitor

Kara New Ski, Donald S.
Kalish, Vincent Jay.
Robinson, Edward Dee.
Ullman, Brett Earl.

JP2000577149A

August 27, 2002

October 22, 1999

Click for automatic bibliography generation  

Aiden Pharmaceuticals, Inc.

A61K31/197; A61K31/222; A61K31/225; A61K31/343; A61K31/351; A61K31/352; A61K31/37; A61K31/381; A61K31/401; A61K31/4035; A61K31/404; A61K31/41; A61K31/415; A61K31/4164; A61K31/4184; A61K31/4196; A61K31/42; A61K31/423; A61K31/4245; A61K31/426; A61K31/428; A61K31/433; A61K31/4402; A61K31/4412; A61K31/445; A61K31/4523; A61K31/47; A61K31/472; A61K31/50; A61K31/505; A61K31/517; A61K31/53; A61K31/662; A61P7/00; A61P9/10; A61P25/00; A61P29/00; A61P37/02; C07C237/22; C07C311/09; C07D207/16; C07D209/42; C07D209/48; C07D211/60; C07D211/86; C07D213/64; C07D215/20; C07D215/22; C07D215/227; C07D215/233; C07D215/24; C07D215/26; C07D217/24; C07D217/26; C07D231/06; C07D231/20; C07D233/84; C07D235/26; C07D235/28; C07D237/14; C07D239/34; C07D239/38; C07D239/88; C07D249/12; C07D249/18; C07D253/08; C07D257/04; C07D261/12; C07D261/20; C07D265/02; C07D271/06; C07D271/10; C07D271/113; C07D277/06; C07D277/20; C07D277/36; C07D277/68; C07D277/74; C07D285/125; C07D307/79; C07D309/30; C07D309/38; C07D311/30; C07D311/46; C07D327/04; C07D333/34; C07D333/62; C07D401/12; C07D401/14; C07D403/12; C07D403/14; C07D405/12; C07F9/32; C07K5/00; C07K5/02; C07K5/078; C07K5/097; C07D285/12; (IPC1-7): C07C237/22; A61K31/197; A61K31/222; A61K31/225; A61K31/343; A61K31/351; A61K31/352; A61K31/37; A61K31/381; A61K31/401; A61K31/4035; A61K31/404; A61K31/41; A61K31/415; A61K31/4164; A61K31/4184; A61K31/4196; A61K31/42; A61K31/423; A61K31/4245; A61K31/426; A61K31/428; A61K31/433; A61K31/4402; A61K31/4412; A61K31/445; A61K31/4523; A61K31/47; A61K31/472; A61K31/50; A61K31/505; A61K31/517; A61K31/53; A61K31/662; A61P7/00; A61P9/10; A61P25/00; A61P29/00; A61P37/02; C07C311/09; C07D207/16; C07D209/42; C07D209/48; C07D211/60; C07D213/64; C07D215/20; C07D215/22; C07D215/24; C07D215/26; C07D217/24; C07D217/26; C07D231/20; C07D233/84; C07D235/28; C07D237/14; C07D239/34; C07D239/38; C07D239/88; C07D249/12; C07D249/18; C07D253/08; C07D257/04; C07D261/12; C07D261/20; C07D271/06; C07D271/10; C07D277/06; C07D277/36; C07D277/68; C07D277/74; C07D285/125; C07D307/79; C07D309/38; C07D311/30; C07D311/46; C07D327/04; C07D401/12; C07D401/14; C07D403/12; C07D403/14; C07D405/12; C07F9/32; C07K5/00

Takashi Ishida (4 others)

Previous Patent: 新規化合物類、それらの調製及び使用

Next Patent: （＋）−エキソ−６−フェニル−３−アザビシクロ−［３．２．０］ヘプ�...